PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+10.06%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.08B
AUM Growth
+$3.08B
(-0.87%)
Cap. Flow
-$95.9M
Cap. Flow
% of AUM
-3.11%
Top 10 Holdings %
Top 10 Hldgs %
37.15%
Holding
94
New
12
Increased
13
Reduced
16
Closed
15
Top Buys
| 1 |
Erasca
ERAS
|
$98.2M |
| 2 |
Caribou Biosciences
CRBU
|
$88.2M |
| 3 |
Cytokinetics
CYTK
|
$52.6M |
| 4 |
SOPHiA GENETICS
SOPH
|
$35.5M |
| 5 |
AstraZeneca
AZN
|
$34.7M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$166M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$68.5M |
| 3 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$43.5M |
| 4 |
Baxter International
BAX
|
$36.9M |
| 5 |
Guardant Health
GH
|
$36.2M |
Sector Composition
| 1 | Healthcare | 94.98% |
| 2 | Financials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AstraZeneca
AZN
$248B
| $47.2M | 1.39% | 785,748 +577,148 | +277% | +$34.7M |
|
27
Gilead Sciences
GILD
$140B
| $46.6M | 1.37% | 666,601 | – | – |
|
|
NVRO
28
DELISTED
NEVRO CORP.
NVRO
| $45.7M | 1.34% | 392,786 -25,859 | -6% | -$3.01M |
|
29
Tenet Healthcare
THC
$16.3B
| $44.3M | 1.3% | 667,073 | – | – |
|
30
Waters Corp
WAT
$18B
| $42M | 1.24% | 117,634 | – | – |
|
31
Icon
ICLR
$13.8B
| $41.4M | 1.22% | 158,183 +13,956 | +10% | +$3.66M |
|
32
Novavax
NVAX
$1.21B
| $40.9M | 1.2% | 197,208 +48,104 | +32% | +$9.97M |
|
33
Thermo Fisher Scientific
TMO
$186B
| $40.8M | 1.2% | 71,442 +36,613 | +105% | +$20.9M |
|
34
Syndax Pharmaceuticals
SNDX
$1.41B
| $35.5M | 1.04% | 1,856,738 -288,143 | -13% | -$5.51M |
|
|
35
SOPHiA GENETICS
SOPH
$234M
| $35.5M | 1.04% | +2,022,552 | New | +$35.5M |
|
36
Heron Therapeutics
HRTX
$207M
| $32M | 0.94% | 2,993,546 +794,489 | +36% | +$8.49M |
|
|
JNCE
37
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $28.6M | 0.84% | 3,848,822 +585,989 | +18% | +$4.35M |
|
|
CANO
38
DELISTED
Cano Health, Inc.
CANO
| $26.6M | 0.78% | 2,094,279 | – | – |
|
|
AERI
39
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $24.9M | 0.73% | 2,182,684 | – | – |
|
40
Intellia Therapeutics
NTLA
$1.22B
| $23.9M | 0.7% | 178,222 | – | – |
|
|
CTLT
41
DELISTED
CATALENT, INC.
CTLT
| $23.7M | 0.7% | +177,800 | New | +$23.7M |
|
|
ADAP
42
Adaptimmune Therapeutics
ADAP
$15.6M
| $22.8M | 0.67% | 4,403,574 +775,674 | +21% | +$4.01M |
|
|
KRTX
43
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $21.7M | 0.64% | 177,091 -16,295 | -8% | -$1.99M |
|
44
Allogene Therapeutics
ALLO
$251M
| $19.9M | 0.59% | 775,819 +169,019 | +28% | +$4.34M |
|
45
Butterfly Network
BFLY
$405M
| $19.1M | 0.56% | 1,828,311 | – | – |
|
46
Molina Healthcare
MOH
$9.8B
| $19M | 0.56% | 70,088 | – | – |
|
|
ISEE
47
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $18.5M | 0.54% | +1,138,112 | New | +$18.5M |
|
48
Stevanato
STVN
$6.28B
| $13.9M | 0.41% | +549,002 | New | +$13.9M |
|
49
Sight Sciences
SGHT
$213M
| $11M | 0.32% | +483,538 | New | +$11M |
|
50
Atea Pharmaceuticals
AVIR
$267M
| $10.6M | 0.31% | +302,532 | New | +$10.6M |
|